The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T

Acta Radiologica

Volumn 55, Issue 1, 2014, Pages 14-23

  Tsougos, Ioannis ^a   Svolos, Patricia ^a   Kousi, Evanthia ^a   Athanassiou, Evangelos ^a   Theodorou, Kiriaki ^a   Arvanitis, Dimitrios ^a   Fezoulidis, Ioannis ^a   Vassiou, Katerina ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

3T; Breast tumor; Diffusion tensor imaging; Spectroscopy

Indexed keywords

DIAGNOSIS; DIFFUSION; DIFFUSION TENSOR IMAGING; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAMMOGRAPHY; SPECTROSCOPY;

3T; APPARENT DIFFUSION COEFFICIENT; BREAST ABNORMALITIES; BREAST MAGNETIC-RESONANCE IMAGING; BREAST TUMOR; DYNAMIC CONTRAST-ENHANCED; FRACTIONAL ANISOTROPY; PROTON MR SPECTROSCOPY;

TENSORS;

CHOLINE; GADOLINIUM;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; FIBROCYSTIC BREAST DISEASE; FRACTIONAL ANISOTROPY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

3T; BREAST TUMOR; DIFFUSION TENSOR IMAGING; SPECTROSCOPY;

ADULT; AGED; ANISOTROPY; BREAST DISEASES; CHOLINE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84896768058     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185113492152     Document Type: Article

References (38)

1. Heywang-Köbrunner SH, Viehweg P, Heinig A, et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24: 94-108.
2. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220: 13-30.
3. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histological findings for the nodes of a breast MR imaging interpretation model. Radiographics 1999;19: 79-92.
4. Yen Y, Han K, Daniel B, et al. Dynamic breast MRI with spiral trajectories: 3D versus 2D. J Magn Reson Imaging 2000;11: 351-359.
5. Malich A, Fischer DR, Wurdinger S, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. Am J Roentgenol 2005;185: 964-970.
6. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006;238: 42-53.
7. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion- weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? Am J Roentgenol 2009;193: 840-849.
8. Mountford C, Ramadan S, Stanwell P, et al. Proton MRS of the breast in the clinical setting. NMR Biomed 2009;22: 54-64.
9. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999;10: 159-164.
10. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo (1) H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8: 1191-1197.
11. Sijens PE, Wijrdeman HK, Moerland MA, et al. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology 1988;169: 615-620.
12. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220: 40-46.
13. Yeung DK, Yang WT, Tse GM. Human breast cancer: in vivo proton MR spectroscopy in the characterization of histopathological subtypes and preliminary observations in axillary node metastases. Radiology 2002;225: 190-197.
14. Cecil KM, Schnall MD, Siegelman ES, et al. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68: 45-54.
15. Kousi E, Tsougos I, Vasiou K, et al. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization. Scientific World Journal 2012;2012:754380.
16. Gribbestad IS, Bakken IJ, Singstad TE, et al. Determination of choline content in breast tumors with H-1 MR spectroscopy: an external standard method. In: Proceedings of the 7th meeting of ISMRM, Berkeley, 1999.
17. Yoshikawa MI, Ohsumi S, Sugata S, et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 2007;25: 218-223.
18. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrastenhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008;28: 1157-1165.
19. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast us. Magn Reson Med Sci 2005;4: 35-42.
20. Rubesova E, Grell AS, De Maertelaer V, et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006;24: 319-24.
21. Kuroki-Suzuki S, Kuroki Y, Nasu K, et al. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007;6: 21-27.
22. Partridge SC, Ziadloo A, Murthy R, et al. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors. J Magn Reson Imaging 2010;31: 339-347.
23. Baltzer PA, Schafer A, Dietzel M, et al. Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol 2011;21: 1-10.
24. Tsougos I, Svolos P, Kousi E, et al. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton-MRS, diffusion and perfusion metrics at 3T. Cancer Imaging 2012;26: 423-436.
25. Sardanelli F, Fausto A, Di Leo G, et al. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. Am J Roentgenol 2009;192: 1608-1617.
26. Hu J, Yu Y, Kou Z, et al. A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time. Magn Reson Imaging 2008;26: 360-366.
27. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94: 1197-1203.
28. Robson ME, Offit K. Breast MRI for women with hereditary cancer risk. JAMA 2004;292: 1368-1370.
29. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in woman with familial or genetic predisposition. N Engl J Med 2004;351: 427-437.
30. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology 1998;209: 499-509.
31. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. Am J Roentgenol 2002;179: 171-178.
32. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59: 80-84.
33. Singer S, Souza K, Thilly WG. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P and 13C-nuclear magnetic resonance (NMR) spectroscopy study. Cancer Res 1995;55: 5140-5145.
34. Ting YT, Sherr D, Degani H. Variations in the energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996;16: 1381-1388.
35. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006;239: 686-692.
36. Roebuck JR, Cecil KM, Schnall MD, et al. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209: 269-275.
37. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7: 23-29.
38. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion- weighted imaging. J Magn Reson Imaging 2002;16: 172-178.